Table 3. Effect of Coenzyme Q10 on Serum Lipoproteins and Plasma Fibrinogen Concentration in the Study Groupsa,b,c.
Coenzyme Q10 | P Valued | Placebo | P Valued | P Valuee | |||
---|---|---|---|---|---|---|---|
Week 0 | Week 12 | Week 0 | Week 12 | ||||
TC, mmol/L | 5.69 ± 0.57 | 4.47 ± 0.33 | < 0.001 | 5.67 ± 0.59 | 4.93 ± 0.57 | < 0.001 | 0.231 |
LDL-C, mmol/L | 3.46 ± 0.34 | 2.70 ± 0.31 | < 0.001 | 3.47 ± 0.34 | 2.70 ± 0.35 | < 0.001 | 0.56 |
HDL-C, mmol/L | 1.15 ± 0.17 | 1.44 ± 0.18 | < 0.001 | 1.15 ± 0.18 | 1.14 ± 0.18 | 0.812 | < 0.001 |
TG, mmol/L | 2.39 ± 1.05 | 2.48 ± 0.12 | 0.324 | 2.23 ± 1.07 | 2.25 ± 0.69 | 0.341 | 0.145 |
Fibrinogen, g/L | 3.88 ± 1.05 | 2.08 ± 0.99 | 0.001 | 3.99 ± 0.88 | 3.87 ± 0.64 | 0.451 | 0.301 |
a Abbreviations: TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; and TG, triglyceride.
b Values are means ± 2SD.
c P value < 0.05 was considered as statistically significant.
d P Value for the comparison of changes within group (paired-sample t test).
e P Value for the comparison of changes between groups (ANCOVA).